Company Comparison
Nimbus Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Nimbus Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Nimbus Therapeutics
A therapeutics company focused on pharmaceutical or medical technology development with limited public information available.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Nimbus Therapeutics
Sector Overlap
Both Nimbus Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.